In summary, IDH1 is a sufficient marker that allows a better separation of primary GBM from other malignant astrocytomas than any other marker and will help to define more accurately this tumor entity in upcoming studies. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).